CTRI/2024/05/067984
Not yet recruiting
未知
A cross-sectional observational study to evaluate oral and dental needs in treated head and neck cancer survivors - NI
Advanced Center for Cancer Treatment Research and Education in Cancer ACTREC Tata Memorial Center0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Advanced Center for Cancer Treatment Research and Education in Cancer ACTREC Tata Memorial Center
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All consenting patients, 18 or more than 18 years of age, reporting in the Dental and Prosthetic Surgery Department at TMH and ACTREC for post\-treatment follow\-up check\-ups will be enrolled in this study. The patients should have completed at least 1 year since the last dose of radiotherapy.
Exclusion Criteria
- •The patients refusing to provide consent for the study. Patients who have not completed one year of the HNC treatment. Patients reporting with recurrence and/or secondary malignancies.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
An observational study to assess proportion of hypothyroid patients having out-of-range serum TSH values despite being on treatment and to probe reasons for the sameHealth Condition 1: null- HypothyroidismCTRI/2011/12/002219Abbott India Limited2,000
Not yet recruiting
Not Applicable
Anti epileptic drugs and bone health - a cross sectional study of Indians with epilepsyCTRI/2024/03/064935itte Universisty Grant
Not yet recruiting
Not Applicable
Comparison of Two Clinical Methods for Prediction of Difficult Airway for anaesthesiaHealth Condition 1: O- Medical and SurgicalCTRI/2024/05/067823KPC Medical College and Hospital
Not yet recruiting
Not Applicable
Awareness and Adherence to Statin and Antiplatelet TherapyCTRI/2023/10/059075Seth GS Medical College KEM Hospital Diamond Jubilee Society Trust
Completed
Not Applicable
Study to assess the prevalence of chronic kidney disease in Type 2 Diabetes.CTRI/2015/05/005769AstraZeneca Pharma India Ltd3,000